C-reactive protein and aetiological subtypes of cerebral infarction

Neurological Sciences

Volumn 29, Issue 4, 2008, Pages 245-249

  Terruzzi, Alessandro ^b   Valente, Laura ^a   Mariani, Roberto ^c   Moschini, Luca ^d   Camerlingo, Massimo ^a  

^a Neurological Unit   (Italy)

^b Stroke Unit   (Italy)

^c Clinical Chemistry Laboratory   (Italy)

^d Policlinico San Marco   (Italy)

Author keywords

Aetiology of stroke; C reactive protein; Cerebral ischaemia; Stroke

Indexed keywords

C REACTIVE PROTEIN;

ACUTE DISEASE; ADULT; AGED; ARTICLE; BLOOD SAMPLING; BRAIN EMBOLISM; BRAIN INFARCTION; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRACTICE GUIDELINE; PREDICTION; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; SURVIVAL TIME;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CEREBRAL INFARCTION; EARLY DIAGNOSIS; FEMALE; HUMANS; INFLAMMATION; INTRACRANIAL EMBOLISM; MALE; MIDDLE AGED; MORTALITY; PREDICTIVE VALUE OF TESTS; PROGNOSIS; TIME FACTORS; UP-REGULATION; YOUNG ADULT;

EID: 53149101716     PISSN: 15901874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10072-008-0975-5     Document Type: Article

References (33)

1. Emsley HC, Smith CJ, Gavin CM et al (2003). An early and sustained peripheral inflammatory response in acute ischaemic stroke: relationships with infection and atherosclerosis. J. Neuroimmunol 139:93-101
2. Anuk T, Assayag EB, Rotstein R et al (2002) Prognostic implications of admission inflammatory profile in acute ischemic neurological events. Acta Neurol Scand 106:196-199
3. Bamford J, Sandercock P, Dennis M et al (1991) Classification and natural history of identifiable subtypes of cerebral infarction. Lancet 337:1521-1526
4. Canova CR, Courtin C, Reinhart WH (1999) C-reactive protein (CRP) in cerebro-vascular events. Atherosclerosis 147:49-53
5. Di Napoli M, Di Gianfilippo G, Sollecito A, Bocola V (2000) C-reactive protein and outcome after first-ever ischemic stroke. Stroke 31:238-239
6. Di Napoli M, Papa F, Bocola V (2001) Prognostic influence of increased C-reactive protein and fibrinogen levels in ischemic stroke. Stroke 32:133-138
7. Di Napoli M, Papa F, Bocola V (2001) C-reactive protein in ischemic stroke: An independent prognostic factor. Stroke 32:917-924
8. Di Napoli M, Papa F (2002) Inflammation, hemostatic markers, and antithrombotic agents in relation to long-term risk of new cardiovascular events in first-ever ischemic stroke patients. Stroke 33:1763-1771
9. Di Napoli M, Schwaninger M, Cappelli R et al (2005) Evaluation of C-reactive protein measurement for assessing the risk and prognosis in ischemic stroke. A statement for health care professionals from CRP pooling project members. Stroke 36:1316-1329
10. Eikelboom JW, Hankey GJ, Baker RI et al (2003) C-reactive protein in ischemic stroke and its etiologic subtypes. J Stroke Cerebrovsc Dis 12:74-81
11. Elkind MSV, Coates K, Tai W et al (2006) Levels of acute phase proteins remain stable after ischemic stroke. BMC Neurology 6:37
12. Masotti L, Ceccarelli E, Forconi S, Cappelli R (2005) Prognostic role of C-reactive protein in very old patients with acute ischaemic stroke. J Int Med 258:145-152
13. Muir KW, Weir CJ, Alwan W et al (1999) C-reactive protein and outcome after ischemic stroke. Stroke 30:981-985
14. Rallidis LS, Vikelis M, Panagiotakos DB et al (2006) Inflammatory markers and in-hospital mortality in acute ischaemic stroke. Atherosclerosis 189:193-197
15. Winbeck K, Poppert H, Etgen T et al (2002) Prognostic relevance of early serial C-reactive protein measurements after first ischemic stroke. Stroke 33:2459-2464
16. Ladenvall C, Jood K, Bloomstrand C et al (2006) Serum C-reactive protein concentration and genotype in relation to ischemic stroke subtypes. Stroke 37:2017-2023
17. Young B, Gleeson M, Cripps AW (1991) C-reactive protein: A critical review. Pathology 23:118-124
18. Adams HP Jr, Bendixen BH, Kappelle JL et al (1993) Classification of subtype of acute ischemic stroke: Definitions for use in a multicentric clinical trial. Stroke 24:35-41
19. Rost NS, Wolf PA, Kase CS et al (2001) Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack. Stroke 32:2575-2579
20. Hashimoto H, Kitagawa K, Hougaku H et al (2001) C-reactive protein is an independent predictor of the rate of increase in early carotid atherosclerosis. Circulation 2001 104:63-67
21. Van Der Meer IM, De Maat MP, Hak AE et al (2002) C-reactive protein predicts progression of atherosclerosis measured at various sites in the arterial tree: The Rotterdam Study. Stroke 33:2750-2755
22. Ross R (1999) Atherosclerosis: An inflammatory disease. N Engl J Med 340:115-126
23. Chapman CML, Beilby JP, McQuillan BM et al (2004) Monocyte count but not C-reactive protein or interleukin-6 I an independent risk marker for subclinical carotid atherosclerosis. Stroke 35:1619-1624
24. Folsom AR, Pankow JS, Tracy RP et al (2005) Association of C-reactive protein with markers of prevalent atherosclerotic disease. Am J Cardiol 88:112-117
25. Lorenz MW, Karbstein P; Markus HS, Sitzer M (2007) High-sensitivity C-reactive protein is not associated with carotid intimamedia progression. The Carotid Atherosclerosis Progression Study. Stroke 38:1774-1779
26. Blake GJ, Ridcker PM (2002) Inflammatory bio-markers and cardiovascular risk prediction. J Intern Med 252:283-294
27. Anderson JL, Maycock ACA, Lappe DL et al (2004) Intermountain heart collaborative study group. Frequency of elevation of C-reactive protein in atrial fibrillation. Am J Cardiol 15:1255-1259
28. Gabay C, Kushner I (1999) Acute-phase proteins and other systemic responses to inflammation. New Engl J Med 340:448-454
29. Dinargl U, Iadecola C, Moskowitz MA (1999) Pathobiology of ischaemic stroke: An integrated view. Trends Neurosci 23:391-397
30. Smith CJ, Emsley HCA, Gavin CM et al (2004) Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome. BMC Neurology 4:2
31. Fieschi C, Argentino C, Lenzi GL et al(1989) Clinical and instrumental evaluation of patients with ischemic stroke seen within the first 6 hours. J Neurol Sci 91:311-322
32. Silver FL, Norris JW, Lewis AJ, Hachinski VC (1984) Early mortality following stroke: A prospective review. Stroke 15:492-496
33. Modrego PJ, Boned B, Berlanga JJ, Serrano M (2008) Plasmatic B-type natriuretic peptide and C-reactive protein in hyperacute stroke as markers of CT evidence of brain edema. Int J Med Sci 5:18-23